Skip to main content
. Author manuscript; available in PMC: 2014 Jun 1.
Published in final edited form as: J Thorac Oncol. 2013 Jun;8(6):796–802. doi: 10.1097/JTO.0b013e3182897bf1

Table 1.

Patient characteristics

Esophagectomy (n=1204) Local Therapy (n=254) p-value

Age (mean, SD), years 64.4 (10.0) 73.4 (9.7) <0.001

Female 190 (15.8%) 60 (23.6%) 0.003

Race
 White 1,111 (92.3%) 240 (94.5%) 0.17
 Black 45 (3.7%) 10 (3.9%)
 Other/Unknown 48 (4.0%) 4 (1.6%)

Marital Status
 Married 850 (70.6%) 164 (64.6%) 0.06
 Other/Unknown 354 (29.4%) 90 (35.4%)

Tumor location
 Mid esophagus 199 (16.5%) 56 (22.1%) 0.04
 Lower esophagus 1,005 (83.5%) 198 (78.0%)

Tumor grade
 G1/2 (well/moderate) 649 (53.9%) 105 (41.3%) <0.001
 G3/4 (poor/undifferentiated) 342 (28.4%) 41 (16.1%)
 Unknown 213 (17.7%) 108 (42.5%)

Histology
 Squamous cell carcinoma 220 (18.3%) 38 (15.0%) 0.21
 Adenocarcinoma 984 (81.7%) 216 (85.0%)

Radiation therapy
 No radiotherapy 957 (79.5%) 217 (85.4%) 0.02
 Beam radiotherapy 242 (20.1%) 34 (13.4%)
 Unknown 5 (0.4%) 3 (1.2%)

Cause of death
 Alive 831 (69.0%) 179 (70.5%) <0.001
 Esophagus 228 (18.9%) 27 (10.6%)
 Other cause of death 145 (12.0%) 48 (18.9%)

Time period
 Early (1998–2003) 487 (40.4%) 48 (18.9%) <0.001
 Late (2004–2008) 717 (59.6%) 206 (81.1%)